The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides, explained: Answers to your top questions Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences Is BPC 157 Legal? Understanding Its Status and Implications BPC 157 Capsules Vios Compounding Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022 Journal of Pharmaceutical Innovation Springer Nature Link